MedTrace Logo

Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery

NCT00457886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2017-03-09

No results posted yet for this study

Summary

The purpose of this study is to measure hormones in the blood known to affect the timing of delivery after a single injection of 17-P in order to help understand its mechanism of action in preventing preterm delivery.

Conditions

  • Preterm Delivery

Sponsors & Collaborators

  • Wedgewood Pharmacy

    collaborator INDUSTRY

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Georgetown University

    lead OTHER

Principal Investigators

  • John Queenan, MD · Georgetown University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-07-31
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00457886 on ClinicalTrials.gov